Allworth Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.5K | Buy |
300
+190
| +173% | +$28.8K | ﹤0.01% | 1993 |
|
|
2025
Q1 | $12.7K | Sell |
110
-34
| -24% | -$3.92K | ﹤0.01% | 2310 |
|
|
2024
Q4 | $24.2K | Sell |
144
-12
| -8% | -$2.01K | ﹤0.01% | 1972 |
|
|
2024
Q3 | $30.7K | Sell |
156
-51
| -25% | -$10K | ﹤0.01% | 1643 |
|
|
2024
Q2 | $45.1K | Buy |
207
+84
| +68% | +$18.3K | ﹤0.01% | 1428 |
|
|
2024
Q1 | $33.3K | Buy |
123
+27
| +28% | +$7.32K | ﹤0.01% | 1486 |
|
|
2023
Q4 | $22.7K | Buy |
96
+29
| +43% | +$6.86K | ﹤0.01% | 1578 |
|
|
2023
Q3 | $13.1K | Sell |
67
-47
| -41% | -$9.21K | ﹤0.01% | 1741 |
|
|
2023
Q2 | $24K | Buy |
114
+78
| +217% | +$16.4K | ﹤0.01% | 1431 |
|
|
2023
Q1 | $7.27K | Sell |
36
-132
| -79% | -$26.6K | ﹤0.01% | 1896 |
|
|
2022
Q4 | $36.6K | Buy |
168
+63
| +60% | +$13.7K | ﹤0.01% | 1136 |
|
|
2022
Q3 | $21K | Sell |
105
-189
| -64% | -$37.8K | ﹤0.01% | 1270 |
|
|
2022
Q2 | $63K | Buy |
294
+14
| +5% | +$3K | ﹤0.01% | 830 |
|
|
2022
Q1 | $80K | Sell |
280
-70
| -20% | -$20K | ﹤0.01% | 777 |
|
|
2021
Q4 | $132K | Buy |
350
+10
| +3% | +$3.77K | ﹤0.01% | 624 |
|
|
2021
Q3 | $140K | Buy |
+340
| New | +$140K | ﹤0.01% | 554 |
|